Lutein and Alzheimer's Disease Study

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Alzheimer's Disease

In brief

Oxidative damage by free radicals may be involved in causing Alzheimer's disease (AD). Free radicals may lead to death of nerve cells and decline in brain function. Certain antioxidants may suppress this free radical damage associated with AD. Carotenoids are a family of naturally occurring antioxidants that have important functions for human health. Carotenoids are known to reduce oxidative damage, but their effects have not been studied in AD patients. The objective of the study is to examine whether lutein supplementation helps to reduce oxidative damage from free radicals in AD patients.

Key facts

Study ID

NCT00596024

Run by

Oregon Health and Science University

People needed

3

Starts

2007-12-01

Expected to finish

2009-07-01

Last updated by the study team

2019-08-12

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with moderately severe Alzheimer's disease

Where it is running

• Oregon Health and Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.